It is well known that the expression of gangliosides is developmental regulated and these developmental changes correlate well with their putative functions in cellular recognition, interaction, and adhesion. The overall objective of this project is to gain a better understanding of the underlying mechanisms regulating ganglioside expression during brain development and in pathological conditions. The guiding principle is that these developmental changes in the expression of gangliosides is tightly regulated by their synthesis and degradation. To achieve this objective, we will continue to study the chemical structure, cellular distribution, and metabolism of gangliosides, and to elucidate their biological functions in the nervous system employing biochemical and molecular biological techniques. Since there are many stage-dependent gangliosides which play a critical role in early brain development, we will isolate them and characterize their structures. We will study the property, structure, cellular and subcellular localization of several glycosyltransferases, particularly those at key regulatory points of ganglioside biosynthetic pathways, by biochemical and immunocytochemical methods. Similar studies will be extended to brain sialidases which play a key role in ganglioside catabolism and may function as novel membrane- adhesion molecules. The regulatory mechanisms for the synthesis of gangliosides during brain development will be investigated by biochemical and molecular biological techniques at several levels, including transcriptional and posttranslational controls. We have discovered that the activities of several sialyltransferases are modulated by a novel phosphorylation/dephosphorylation mechanism and this observation will be further investigated. We have developed novel strategies to manipulate ganglioside synthesis and expression in cells by using antisense oligonucleotide and gene engineering techniques to study the function of gangliosides in relation to cellular differentiation and proliferation. An understanding of the molecular mechanisms underlying the differential expression of cell surface gangliosides should greatly enrich our knowledge in their functions in normal brain development as well as in neurological disorders that result in mental retardation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS011853-23
Application #
2460486
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1988-07-01
Project End
1999-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
23
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Physiology
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Itokazu, Yutaka; Wang, Jing; Yu, Robert K (2018) Gangliosides in Nerve Cell Specification. Prog Mol Biol Transl Sci 156:241-263
Itokazu, Yutaka; Tsai, Yi-Tzang; Yu, Robert K (2017) Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells. Glycoconj J 34:749-756
Tsai, Yi-Tzang; Itokazu, Yutaka; Yu, Robert K (2016) GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells. Neurochem Res 41:107-15
Yu, Robert K; Usuki, Seigo; Itokazu, Yutaka et al. (2016) Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro. Glycobiology 26:63-73
Koon, Noah A; Itokazu, Yutaka; Yu, Robert K (2015) Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer's Disease Model Mice. ASN Neuro 7:
Itokazu, Yutaka; Yu, Robert K (2014) Amyloid ?-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling. Mol Neurobiol 50:186-96
Usuki, Seigo; O'Brien, Dawn; Rivner, Michael H et al. (2014) A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples. J Immunol Methods 408:52-63
Parameswaran, Reshmi; Lim, Min; Arutyunyan, Anna et al. (2013) O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia. J Exp Med 210:805-19
Wang, Jing; Yu, Robert K (2013) Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc Natl Acad Sci U S A 110:19137-42
Ariga, Toshio; Itokazu, Yutaka; McDonald, Michael P et al. (2013) Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1a?. ASN Neuro 5:141-8

Showing the most recent 10 out of 199 publications